Europe Insulin Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Insulin Market – By Type

1.3.2 Europe Insulin Market – By Country

2. Europe Insulin Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Insulin Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.2.1 Expert Opinion

5. Europe Insulin Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Incidence of Diabetes

5.1.2 Rapid Technological Developments in Insulin Delivery Devices by Major Players

5.2 Market Restraints

5.2.1 Risks Associated with Insulin Delivery Devices

5.3 Market Opportunities

5.3.1 Insufficient Competition from Biosimilars

5.4 Future Trends

5.4.1 Regeneration of Diabetic Pancreas with Advanced Transplants

5.5 Impact Analysis

6. Insulin Market– Europe Analysis

6.1 Europe Insulin Market Revenue Forecast and Analysis

7. Europe Insulin Market Analysis – By Type

7.1 Overview

7.2 Europe Insulin Market Revenue Share, by Type (2021 and 2028)

7.3 Long Acting Insulin

7.3.1 Overview

7.3.2 Long Acting Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Levemir

7.3.2.1.1 Overview

7.3.2.1.2 Levemir: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Lantus

7.3.2.2.1 Overview

7.3.2.2.2 Lantus: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Basaglar

7.3.2.3.1 Overview

7.3.2.3.2 Basaglar: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.4 Tresiba

7.3.2.4.1 Overview

7.3.2.4.2 Tresiba: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Rapid Acting Insulins

7.4.1 Overview

7.4.2 Rapid Acting Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Novolog

7.4.2.1.1 Overview

7.4.2.1.2 Novolog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Humalog

7.4.2.2.1 Overview

7.4.2.2.2 Humalog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.3 Admelog

7.4.2.3.1 Overview

7.4.2.3.2 Admelog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.4 Others

7.4.2.4.1 Overview

7.4.2.4.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Short Acting Insulins and Traditional Human Insulins

7.5.1 Overview

7.5.2 Short Acting Insulins and Traditional Human Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Novolin R

7.5.2.1.1 Overview

7.5.2.1.2 Novolin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Humulin R

7.5.2.2.1 Overview

7.5.2.2.2 Humulin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Insuman

7.5.2.3.1 Overview

7.5.2.3.2 Insuman: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.4 Others

7.5.2.4.1 Overview

7.5.2.4.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Concentrated Insulins and Combination Insulins

7.6.1 Overview

7.6.2 Concentrated Insulins and Combination Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.1 NovoMix

7.6.2.1.1 Overview

7.6.2.1.2 NovoMix: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.2 Ryzodeg

7.6.2.2.1 Overview

7.6.2.2.2 Ryzodeg: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.3 Xultophy

7.6.2.3.1 Overview

7.6.2.3.2 Xultophy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.4 Soliqua/Suliqua

7.6.2.4.1 Overview

7.6.2.4.2 Soliqua/Suliqua: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Biosimilar Insulins

7.7.1 Overview

7.7.2 Biosimilar Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.1 Insulin Glargine

7.7.2.1.1 Overview

7.7.2.1.2 Insulin Glargine: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.2 Human Insulin

7.7.2.2.1 Overview

7.7.2.2.2 Human Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Glucagon-like peptide-1 (GLP-1)

7.8.1 Overview

7.8.2 Glucagon-like peptide-1 (GLP-1): Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.9 Pens and Needles

7.9.1 Overview

7.9.2 Pens and Needles: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.10 Others

7.10.1 Overview

7.10.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Insulin Market – Country Analysis

8.1 Overview

8.1.1 Europe: Insulin Market, by Country, 2021 & 2028 (%)

8.1.1.1 Germany: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.1.1 Germany: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.1.2 Germany: Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.1.1.2.1 Germany: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.1.2.2 Germany: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.1.1.2.3 Germany: Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.1.2.4 Germany: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.1.2.5 Germany: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.2 France: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.2.1 France: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.2.2 France : Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.1.2.2.1 France : Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.2.2.2 France : Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.1.2.2.3 France : Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.2.2.4 France : Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.2.2.5 France : Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.3 UK: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.3.1 UK: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.3.2 UK: Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.1.3.2.1 UK: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.3.2.2 UK: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.1.3.2.3 UK: Insulin Market, By Short-acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.3.2.4 UK: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.3.2.5 UK: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.4 Italy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.4.1 Italy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.4.2 Italy: Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.1.4.2.1 Italy: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.4.2.2 Italy: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.1.4.2.3 Italy: Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.4.2.4 Italy: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.4.2.5 Italy: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.5 Spain: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.5.1 Spain: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.5.2 Spain: Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.1.5.2.1 Spain: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.5.2.2 Spain: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.1.5.2.3 Spain: Insulin Market , By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.5.2.4 Spain: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.5.2.5 Spain: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.6 Rest of Europe: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.6.1 Rest of Europe: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.6.2 Rest of Europe: Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.1.6.2.1 Rest of Europe: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.6.2.2 Rest of Europe: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.1.6.2.3 Rest of Europe: Insulin Market, By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.6.2.4 Rest of Europe: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.6.2.5 Rest of Europe: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

9. Europe Insulin Market–Industry Landscape

9.1 Overview

9.2 Organic Developments

9.2.1 Overview

9.3 Inorganic Developments

9.3.1 Overview

10. Company Profile

10.1 Eli Lilly and Company

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Novo Nordisk A/S

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Biocon

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Wockhardt

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Adocia

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 GlaxoSmithKline plc.

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Sanofi

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Pfizer Inc.

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 Merck & Co., Inc.

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Products and Services

10.9.4 Financial Overview

10.9.5 SWOT Analysis

10.9.6 Key Developments

10.10 Tonghua Dongbao Pharmaceutical Co., Ltd.

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Products and Services

10.10.4 Financial Overview

10.10.5 SWOT Analysis

10.10.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Insulin Market, Revenue and Forecast, 2019–2028 (US$ Million)

Table 2. Germany: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. Germany: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 4. Germany: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 5. Germany: Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 6. Germany: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 7. Germany: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 8. France: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. France : Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 10. France : Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 11. France : Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 12. France : Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 13. France : Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 14. UK: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. UK: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 16. UK: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 17. UK: Insulin Market, By Short-acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 18. UK: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 19. UK: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 20. Italy: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 21. Italy: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 22. Italy: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 23. Italy: Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 24. Italy: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 25. Italy: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 26. Spain: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 27. Spain: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 28. Spain: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 29. Spain: Insulin Market , By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 30. Spain: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 31. Spain: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 32. Rest of Europe: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 33. Rest of Europe: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 34. Rest of Europe: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 35. Rest of Europe: Insulin Market, By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 36. Rest of Europe: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 37. Rest of Europe: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 38. Organic Developments in the Insulin Market

Table 39. Inorganic Developments in the Insulin Market

Table 40. Glossary of Terms, Insulin Market

LIST OF FIGURES

Figure 1. Europe Insulin Market Segmentation

Figure 2. Europe Insulin Market Segmentation, By Country

Figure 3. Europe Insulin Market Overview

Figure 4. The Long Acting Insulin Segment Held Largest Share of Type in the Insulin Market

Figure 5. Germany Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Europe PEST Analysis

Figure 7. Expert Opinion

Figure 8. Europe Insulin Market Impact Analysis of Drivers and Restraints

Figure 9. Europe Insulin Market– Revenue Forecast and Analysis

Figure 10. Europe Insulin Market Revenue Share, by Type (2021 and 2028)

Figure 11. Europe Long Acting Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Europe Levemir: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Europe Lantus: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Europe Basaglar: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Europe Tresiba: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Europe Rapid Acting Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Europe Novolog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Europe Humalog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Europe Admelog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Europe Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe Short Acting Insulins and Traditional Human Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Europe Novolin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Europe Humulin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Europe Insuman: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Europe Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Europe Concentrated Insulins and Combination Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe NovoMix: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Europe Ryzodeg: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Europe Xultophy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Europe Soliqua/Suliqua: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Europe Biosimilar Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Europe Insulin Glargine: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Europe Human Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Europe Glucagon-like peptide-1 (GLP-1): Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Europe Pens and Needles: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Europe Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Europe: Insulin Market, by Key Country – Revenue (2021) (US$ Million)

Figure 38. Europe: Insulin Market, by Country, 2021 & 2028 (%)

Figure 39. Germany: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. France: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. UK: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. Italy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. Spain: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. Rest of Europe: Insulin Market – Revenue and Forecast to 2028 (US$ Million)